Skip to main page content

• HOME
• Current Issue
• Archive
• Alerts
• About ASM
• Contact us
• Tech Support
• Journals.ASM.org

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Grimek, T. L. Articles by Escalante-Semerena, J. C. Search for Related Content PubMed PubMed Citation Articles by Grimek, T. L. Articles by Escalante-Semerena, J. C.

 Previous Article  |  Next Article 

Journal of Bacteriology, August 2003, p. 4837-4843, Vol. 185, No. 16
0021-9193/03/$08.00+0     DOI: 10.1128/JB.185.16.4837-4843.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.

Residues C123 and D58 of the 2-Methylisocitrate Lyase (PrpB) Enzyme of Salmonella enterica Are Essential for Catalysis

T. L. Grimek,¹ H. Holden,² I. Rayment,² and J. C. Escalante-Semerena^1*

Departments of Bacteriology,¹ Biochemistry, University of Wisconsin—Madison, Madison, Wisconsin²

Received 10 March 2003/ Accepted 13 May 2003

Top Abstract Introduction Materials and Methods Results Discussion References

 
The prpB gene of Salmonella enterica serovar Typhimurium LT2 encodes a protein with 2-methylisocitrate (2-MIC) lyase activity, which cleaves 2-MIC into pyruvate and succinate during the conversion of propionate to pyruvate via the 2-methylcitric acid cycle. This paper reports the isolation and kinetic characterization of wild-type and five mutant PrpB proteins. Wild-type PrpB protein had a molecular mass of approximately 32 kDa per subunit, and the biologically active enzyme was comprised of four subunits. Optimal 2-MIC lyase activity was measured at pH 7.5 and 50°C, and the reaction required Mg²⁺ ions; equimolar concentrations of Mn²⁺ ions were a poor substitute for Mg²⁺ (28% specific activity). Dithiothreitol (DTT) or reduced glutathione (GSH) was required for optimal activity; the role of DTT or GSH was apparently not to reduce disulfide bonds, since the disulfide-specific reducing agent Tris(2-carboxyethyl)phosphine hydrochloride failed to substitute for DTT or GSH. The K_m of PrpB for 2-MIC was measured at 19 µM, with a k_cat of 105 s^-1. Mutations in the prpB gene were introduced by site-directed mutagenesis based on the active-site residues deemed important for catalysis in the closely related phosphoenolpyruvate mutase and isocitrate lyase enzymes. Residues D58, K121, C123, and H125 of PrpB were changed to alanine, and residue R122 was changed to lysine. Nondenaturing polyacrylamide gel electrophoresis indicated that all mutant PrpB proteins retained the same oligomeric state of the wild-type enzyme, which is known to form tetramers. The PrpB^K121A, PrpB^H125A, and PrpB^R122K mutant proteins formed enzymes that had 1,050-, 750-, and 2-fold decreases in k_cat for 2-MIC lyase activity, respectively. The PrpB^D58A and PrpB^C123A proteins formed tetramers that displayed no detectable 2-MIC lyase activity indicating that both of these residues are essential for catalysis. Based on the proposed mechanism of the closely related isocitrate lyases, PrpB residue C123 is proposed to serve as the active site base, and residue D58 is critical for the coordination of a required Mg²⁺ ion.

Top Abstract Introduction Materials and Methods Results Discussion References

 
Propionate catabolism in Salmonella enterica serovar Typhimurium LT2 (herein referred to as serovar Typhimurium) occurs via the 2-methylcitric acid (2-MC) cycle (Fig. 1) (18). The 2-MC cycle of propionate metabolism was first identified in the yeast Yarrowia lipolytica and several years later was found to exist in prokaryotes (8, 18, 36, 37). The prokaryotic enzymes of this pathway have been characterized. PrpE is the propionyl coenzyme A synthetase (14, 17), PrpC is the 2-MC synthase (18, 39), PrpD is the 2-MC dehydratase (8, 15), and PrpB is the 2-methylisocitrate (2-MIC) lyase (7, 18). This work focuses on the serovar Typhimurium PrpB enzyme, which catalyzes the cleavage of 2-MIC into pyruvate and succinate (15).

View larger version (21K): [in this window] [in a new window]

FIG. 1. 2-MC cycle of serovar Typhimurium. The boxed area of the scheme highlights the reaction catalyzed by the 2-MICL (PrpB) enzyme, the focus of the present work.

Comparisons of the amino acid sequence of the PrpB protein to other protein sequences identified it as a homolog of carboxyphosphonoenolpyruvate (CPEP) mutase, phosphoenolpyruvate (PEP) mutase, and isocitrate lyases (ICL) (16). The mutases are anabolic enzymes used for the production of secondary metabolites and the only enzymes known to create a carbon-phosphorus bond (13, 27), while the lyases are catabolic enzymes (18, 24, 43). Even though the reactions catalyzed by these enzymes are different, they are all proposed to proceed via mechanisms that stabilize enol(ate) intermediates (32). Based on the similarities shared by these enzymes, it has been proposed that these proteins represent a new /ß-barrel superfamily (19). The /ß-barrel proteins are known to be a very diverse group of enzymes that may catalyze different reactions by binding substrate differently inside the barrel. The evolutionary link between the mutases and the lyases is strengthened by the fact that the key active-site residues required for PEP mutase catalysis are invariant in the lyases (19). Although the PrpB enzyme catalyzes a reaction similar to that catalyzed by ICL, the PrpB enzyme shares more sequence identity with CPEP and PEP mutases (36 and 30% end-to-end identity, respectively) than with ICL (ca. 20% identity).

Structure-function analyses of PEP mutase have shed valuable insights into how this enzyme and probably how ICL and 2-MIC lyase (2-MICL) enzymes may work. Early studies of the PEP mutase mechanism entertained the possibility that residue D58 could serve as a phosphoryl group acceptor during a reaction involving a modified enzyme intermediate (20). Recently reported evidence, however, ruled out a phosphoryl transfer mechanism directly involving residue D58, and proposed that PEP mutase catalyzes the phosphoryl transfer via a dissociative mechanism with residues R159 and H190 residues holding the phosporyl-metaphosphate-phosphonyl group stationary during the reaction (23). Mechanisms of catalysis have also been proposed for the ICL proteins based on three-dimensional structures and data from active-site mutant proteins (5, 6, 34). Based on ICL structures with bound inhibitors and previous inhibition experiments using 3-bromopyruvate and iodoacetate, it was concluded that a cysteinyl residue was most likely the active-site residue required for isocitrate cleavage (5, 6, 21, 26, 34). It is interesting that an equivalently positioned cysteinyl residue is not conserved in PEP mutase, yet is conserved in CPEP mutase and the lyases (Fig. 2). Crystal structures of ICL from three different organisms have revealed an electronegative depression which is responsible for the binding of a Mg²⁺ ion in each of the structures; this negatively charged region is created by four carboxyl groups corresponding to residues D58, D85, D87 and E115 of serovar Typhimurium PrpB (5, 6, 34).

View larger version (16K): [in this window] [in a new window]

FIG. 2. PrpB homologs. Amino acid sequence alignments between serovar Typhimurium (S.T.) PrpB, E. coli K-12 (E.c.) PrpB, Streptomyces hygroscopicus CPEP mutase (S.h. CPEPmu), M. edulis PEP mutase (M.e. PEPmu) and E. coli K-12 ICL. Boxed residues correspond to those implicated in the PEP mutase or ICL reaction mechanisms as described in the text. Serovar Typhimurium PrpB protein sequence was compared with sequences deposited in GenBank using the BLAST algorithm (1, 2). Sequence alignments between serovar Typhimurium PrpB and other homologs were performed by ClustalW (40).

Recent studies compared 2-MICL activities of PrpB proteins from Aspergillus nidulans and Escherichia coli (7). However, these studies did not look into the roles of specific amino acid residues in the reaction mechanism of PrpB from these organisms. Work reported here was undertaken to investigate the importance of active-site residues of PrpB from serovar Typhimurium. This work reports the cloning, isolation, and biochemical characterization of the wild-type PrpB and five site-directed PrpB mutant proteins. The data obtained from the kinetic analysis of the purified enzymes indicate that residues C123 and D58 are crucial for PrpB 2-MICL activity. During the review of this paper, the three-dimensional crystal structure of apo-PrpB enzyme from E. coli was published (11). The lack of substrate in the active site of the enzyme, however, resulted in a disordered C123 residue; hence, its role in the reaction could not be established. However, the reported model postulated a role of residue D58 consistent with the conclusions of the work reported in this paper.

Top Abstract Introduction Materials and Methods Results Discussion References

 
Chemicals and culture media. Chemicals and rabbit muscle lactate dehydrogenase (LDH) were obtained from Sigma Chemical (St. Louis, Mo.). Restriction enzymes, dithiothreitol (DTT), and deoxyribonucleoside triphosphates were purchased from Promega (Madison, Wis.); primers were synthesized by IDTDNA (Coralville, Iowa); NaCl, MgCl₂, 2-(4-morpholino)-ethanesulfonic acid (MES), HEPES, N-[2-hydroxyethylpiperazine-N'-[3-propanesulfonic acid] (EPPS), kanamycin (KAN), and ampicillin (AMP) were acquired from Fisher Biotech (Itasca, Ill.); Tris(2-carboxyethyl)phosphine hydrochloride (TCEP^.HCl) was purchased from Pierce Chemical Co. (Rockford, Ill.); His-bind resin and thrombin cleavage kits were obtained from Novagen (Madison, Wis.); Luria-Bertani (LB) medium was purchased from Difco (Detroit, Mich.); threo-2-MIC was a kind gift from W. W. Cleland (31). The genotypes of strains and plasmids used in this work are shown in Table 1.

View this table: [in this window] [in a new window]

TABLE 1. Strains and plasmids used in this studya

Construction of plasmids. (i) Plasmid pPRP65.
A 1-kb NdeI-BamHI fragment from plasmid pPRP19 (16) containing the prpB gene was ligated into the cloning vector pET-15b (Novagen) cut with the same enzymes. The resulting plasmid, pPRP65 bla⁺, contained a prpB gene that encoded an N-terminally tagged hexahistidine (H₆PrpB) fusion protein.

(ii) Plasmid pPRP75.
A 1-kb XbaI fragment from plasmid pPRP65 was ligated into the arabinose-inducible vector pBAD30 (12) and transformed into the restriction-deficient modification-proficient serovar Typhimurium strain JR501 (41) as described (33). The resultant colonies were screened for the prpB gene in the correct orientation and the resulting plasmid was named pPRP75.

(iii) Plasmids pPRP76, pPRP78-80, and pPRP131.
Site-directed mutagenesis was performed via the three-primer PCR mutagenesis (25) using plasmid pPRP65 as a template. Primers were designed flanking the T7 promoter and T7 terminator sites of plasmid pPRP65; primer site 5'-GAATTGTGAGCGGATAAC-3' for the T7 promoter region, and primer site 5'-AGCCAACTAAGCTTCCTTTCGG-3' for the T7 terminator region. Mutagenic primers contained 5' phosphorylation modifications; sequences of the primers used are available upon request. PCR amplification products were purified using the QIAquick PCR Purification kit (Qiagen) and cut with the restriction enzyme XbaI. The restriction fragments were cleaned and ligated with plasmid pBAD30 cut with XbaI. Ligation products were introduced into electrocompetent cells of strain JR501 via electroporation and these cells were transferred onto LB plates supplemented with AMP (100 µg/ml). Colonies were screened for vector containing insert in the correct orientation. Each plasmid was sequenced using pBAD30 primers (pBAD30-3', 5'-GGCTGAAAATCTTCTCTCAT-3'; pBAD30-5', 5'-CAACTCTCTACTGTTTCTTT-3') to determine whether the correct mutation was incorporated into the prpB gene and that no other mutations were introduced during amplification. PCR sequencing reactions were prepared using Big Dye (Biotechnology Center, University of Wisconsin—Madison). Reactions were purified in AutoSeq G-50 columns (Pharmacia Biotech), dried in a SpeedVac concentrator (Savant), and sequenced at the Biotechnology Center (University of Wisconsin—Madison). Plasmids were named pPRP76 (prpB^D58A), pPRP78 (prpB^H125A), pPRP79 (prpB^C123A), pPRP80 (prpB^K121A), and pPRP131 (prpB^R122K) (Table 1). Plasmids from strain JR501 were introduced into desired genetic backgrounds by transformation (29).

(iv) Plasmids pPRP82, pPRP84-86, and pPRP132.
Plasmids pPRP76, pPRP78-80, and pPRP131 were cut with NcoI-HindIII and ligated into plasmid pET15b cut with the same enzymes to yield plasmids pPRP82, pPRP84-86, and pPRP132, respectively. prpB alleles in plasmid pET15b were used to overproduce mutant PrpB proteins.

Sequencing mutant alleles of prpB. To determine the locations of prpB mutations in strains JE3946 and JE3961, overnight cultures were grown in LB medium and boiled in sterile water (1:10 dilutions) as templates. PCRs were prepared with 10 µl of template in a 100-µl reaction containing 50 pmol of each primer, a 0.2 mM concentration of each deoxyribonucleoside triphosphate, and 3 U of ENZY+ DNA polymerase (Enzypol Ltd.) according to the manufacturer's instructions. Reactions were performed in a GeneAmp PCR system 2400 (Perkin-Elmer, Norwalk, Conn.) using the following conditions: 30 cycles at 95°C for 1 min, 50°C for 1 min, and 72°C for 1 min. Primers used were 5'-CTCGCTGCCTCTTTGCCTGGC-3' (60 bp upstream of prpB) and 5'-GCATTGCCTGATGGCGGCTTCG-3' (23 bp downstream of prpB). Amplified DNA was purified using the QIAquick PCR purification kit (Qiagen). PCR sequencing reactions were carried out as described above.

Complementation analysis. Plasmids pBAD30, pPRP21, pPRP75-6, pPRP78-80, and pPRP131 were each introduced into mutant strain JE3946. These resulting strains were grown overnight in LB medium containing AMP (100 µg/ml). Four microliters of each overnight culture was inoculated into wells of a 96-well Falcon (Becton Dickinson) microtiter dish containing 200 µl of a no-carbon E (NCE) medium (3) with methionine (0.5 mM), propionate (30 mM), MgSO₄ (1 mM), glycerol (1 mM), AMP (50 µg/ml), and various amounts of L-(+)-arabinose (0, 50, 100, 250, or 500 µM). The density of the cultures in the wells was monitored at 650 nm with a SpectraMAX Plus spectrophotometer (Molecular Devices). The plate chamber was maintained at 37°C. Absorbance measurements were taken every 15 min for 72 h with agitation (780 s) between reads.

Overproduction and purification of H₆PrpB and mutant proteins. Plasmids pPRP65, pPRP82, pPRP84-86, and pPRP132 were introduced into serovar Typhimurium strain JE5256 [metE205 ara-9 prpB121::Tn10d(Tc)/pGP1-2 rpo⁺ kan⁺]. The resulting strains were used to overproduce and purify PrpB and the PrpB variant proteins. Each strain was inoculated into 25 ml of LB broth containing AMP (100 µg/ml) and KAN (60 µg/ml) at 30°C. From the overnight cultures, 20 ml was inoculated into 2 liters of LB broth supplemented with AMP (100 µg/ml) and KAN (60 µg/ml). Cultures were grown in at 30°C to an A₅₉₀ of 0.5 and transferred to a 42°C water bath for 1 h to induce synthesis of the T7 RNA polymerase. Cultures were incubated for 4 h at 37°C and harvested by centrifugation at 11,700 x g with a SS34 rotor for 10 min in a Sorvall RC-5B refrigerated centrifuge (DuPont). Cell pellets were resuspended in 40 ml of 20 mM Tris-HCl buffer, pH 7.9, containing 0.5 M NaCl and 5 mM imidazole. Cells were broken with a French pressure cell at 10⁴ kPa. Cellular debris was discarded after centrifugation at 39,000 x g for 45 min at 4°C. H₆PrpB and mutant proteins were isolated from crude supernatants by nickel-affinity chromatography according to the manufacturer's (Novagen) instructions. Proteins were separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) (22) with 12% polyacrylamide gels and visualized by Coomassie blue R-250 staining (30). Fractions containing purified (>95%) H₆PrpB wild-type and mutant proteins were dialyzed overnight at 4°C against 1 liter of K⁺ HEPES buffer (pH 7.5; 50 mM), EDTA (2.5 mM), and DTT (5 mM). Proteins were then dialyzed twice into 1 liter K⁺ HEPES buffer, pH 7.5 (50 mM), and DTT (5 mM) for 2 h each. The hexahistidine tag was removed with the thrombin cleavage capture kit of Novagen according to the manufacturer's instructions. Resulting PrpB proteins had three extra amino acids at its N terminus (Gly, Ser, and His). Detagged proteins were dialyzed into 1 liter of K⁺ HEPES buffer (pH 7.5; 50 mM) and DTT (5 mM) for 2 h. Glycerol (5% [vol/vol] final concentration) was added to each protein solution. The proteins were flash-frozen as drops in liquid nitrogen and stored at -85°C. The yield obtained under these conditions was 25 mg of protein per liter of culture. No detectable loss of activity was observed after 6 months of storage.

2-MICL assay. Protein concentrations were determined by the method of Bradford (4) using a standard curve generated with bovine serum albumin (Sigma). Lyophilized 2-MIC was dissolved in 0.6 M NaOH and heated at 90°C for 45 min to saponify the lactone ring. Saponified 2-MIC was diluted into 50 mM HEPES buffer, pH 7.5, before use in assays. The reaction mixture (final volume,1 ml) for the 2-MICL assay contained K⁺ HEPES buffer (pH 7.5; 50 mM), MgCl₂ (2.5 mM), DTT (5 mM), rabbit muscle LDH (1 U), NADH (250 µM), PrpB protein, and various concentrations of 2-MIC. Detagged PrpB protein was used in all assays unless specified otherwise. The progress of the reaction was monitored as a decrease in absorbance at 340 nm in a computer-controlled Perkin-Elmer Lambda 40 UV/VIS spectrophotometer (Perkin-Elmer). The assay cuvettes were maintained at 37°C with a circulating water bath. The extinction coefficient for NADH at 37°C was taken to be 6,110 mM^-1 cm^-1 (10). Inactive PrpB mutant proteins were tested for 2-MIC cleavage over 24 h. For this purpose, PrpB protein (up to 100 µg) was added to K⁺ HEPES buffer (pH 7.5; 50 mM), MgCl₂ (2.5 mM), and DTT (5 mM) in sealed vials, the headspace was flushed with N₂ for 15 min, and these vials were incubated at 30°C for 24 h. Activity was assayed by adding rabbit muscle LDH (1 U) and NADH (250 µM) and monitored for a decrease in absorbance at 340 nm as described above.

Optimization of assay conditions. For coupled assays, the amount of LDH in the reaction mixture was maintained at an activity level of at least 10-fold excess over that of the PrpB protein.

pH. The average of at least three independent reactions is reported using the following buffers: MES, pH 6.0 and 6.5; HEPES, pH 7.0, 7.5, and 8.0; and EPPS, pH 8.5.

Temperature. To determine the temperature profile of the reaction the assay mixture without enzyme was preincubated at the specified temperatures for 5 min and the reaction was started by the addition of PrpB protein. The stability of PrpB proteins at different temperatures was assessed by incubation at the specified temperature for 10 min and then assaying for 2-MICL activity at 37°C.

Metal requirement and ionic strength. Assays were conducted as described above with either variation of the concentration of MgCl₂ (0 to 5 mM), replacement of MgCl₂ with MnCl₂ (5 mM), or addition of NaCl (0 to 250 mM) to the assay mixture.

Kinetic analyses. Kinetic constants for PrpB activity were determined by varying the concentration of 2-MIC. Assay sets contained at least 10 points and each set was performed in quadruplicate. Initial velocity data were analyzed using the program GraFit (version 4.0; Erithacus Software Ltd., Staines, United Kingdom). The k_cat values were calculated from V_max and [E] according to the equation k_cat = V_max/[E] where V_max is the maximal velocity (determined from the GraFit results) and [E] is the molar concentration of the PrpB tetramer based on protein concentrations as determined by the Bradford assay (4).

ICL assay. Due to the low detection limit of glyoxylate by the 2-MICL assay utilizing LDH as a coupling enzyme, a phenylhydrazine assay was used to test for isocitrate cleavage by PrpB and PrpB^R122K enzymes. The reaction mixture contained 2.5 mM MgCl₂, 4 mM phenylhydrazine-HCl, and 5 mM DTT. Progress of the reaction was monitored at 324 nm. Commercially available ICL (Sigma) was used as positive control. Reactions were also allowed to proceed for 24 h to determine if any remaining activity was associated with mutant proteins. The extinction coefficients of glyoxylate-phenylhydrazone (16.8 mM^-1 cm^-1) and pyruvate phenylhydrazone (10.2 mM^-1 cm^-1) have been reported (38).

Immunoblot analysis. Serovar Typhimurium strains JE3946 and JE3961 carry mutant prpB alleles (16). These strains along with prpB⁺ strain TR6583 were grown overnight in 5 ml of an NCE medium (3) supplemented with methionine (0.5 mM), MgSO₄ (1 mM), glycerol (22 mM), and propionate (5 mM) to induce expression of the prpBCDE operon (42). One milliliter of each culture was harvested, cells were broken open with BugBuster (Novagen) according to the manufacturer's specifications, and 15 µg of protein from each cell extract was resolved by SDS-PAGE (22). Protein was transferred to nitrocellulose membrane and blocked with powdered milk (45). Blots were probed using polyclonal anti-PrpB antibodies generated against purified H₆PrpB protein at the University of Wisconsin—Madison Animal Care Unit. Blots were probed with donkey anti-rabbit immunoglobulin G conjugated to horseradish peroxidase (Pierce) and developed with ECLPlus Western blotting detection system (Amersham Pharmacia, Little Chalfont, Buckinghamshire, England).

Top Abstract Introduction Materials and Methods Results Discussion References

 
Overproduction and purification of H₆PrpB protein. Serovar Typhimurium strain JE5256 [metE205 ara-9 prpB121::Tn10d(Tc)/pGP1-2 rpo⁺ kan⁺] was used to overexpress prpB from plasmid pPRP65. This strain and another containing pET15b (vector-only control) were grown under conditions that overexpressed prpB. H₆PrpB protein was purified using Ni-affinity chromatography. Samples were analyzed by SDS-PAGE (Fig. 3). H₆PrpB was identified as the prominent 34-kDa band from crude whole-cell extracts. This band was absent in cell extracts of the control strain. Soluble H₆PrpB protein was separated by centrifugation from insoluble protein. Homogenous H₆PrpB protein was treated with thrombin protease to remove the hexahistidine tag. The resulting protein (32 kDa) was greater than 95% pure.

View larger version (85K): [in this window] [in a new window]

FIG. 3. Overproduction and purification of hexahistidine-tagged and detagged PrpB proteins. Lanes: Standards, Novagen Perfect Protein SDS-PAGE markers; Vector-only, pET15b vector-only control; Induced, H6PrpB overproduction; Soluble and Insoluble, soluble and insoluble protein of H6PrpB overproduction cell extracts, respectively; H6PrpB, purification of H6PrpB after nickel chelation-affinity chromatography; PrpB, purified detagged PrpB after cleavage with thrombin.

Characterization of the 2-MICL activity. Kinetic parameters for the 2-MICL activity were determined using the continuous spectrophotometric assay described above to detect pyruvate. The pH optimum for 2-MICL activity was measured between 7.5 and 8.0. The PrpB enzyme showed almost maximal activity at pH 8.5 (96%) but retained only 16% of its specific activity at pH 6.0. pH values above 8.5 were not tested due to the low activity of the coupling enzyme LDH at higher pH. 2-MICL activity increased as a function of temperature up to 50°C; at 60°C, the enzyme lost all detectable activity, most likely due to the instability of the protein fold at high temperature. Although maximal activity was measured at 50°C, the more physiological temperature of 37°C was used for assays. For temperature stability analysis, the PrpB enzyme was incubated for 10 min at different temperatures and then assayed for activity at 37°C. The PrpB enzyme showed no decrease in specific activity when preincubated at 30 and 37°C, but only retained 14% of its activity after preincubation at 50°C. PrpB retained no detectable activity after preincubation at 60°C.

Requirement for a reducing agent. The PrpB enzyme from serovar Typhimurium required a reducing agent (DTT or reduced glutathione) for maximal activity. PrpB protein dialyzed for 4 h at 4°C in buffer without DTT lost all detectable activity. Partial activity (approximately 50%) was restored when the enzyme was incubated in the presence of 5 mM DTT for 15 min. However, greater than 95% of the original activity was retained if dialysis was performed for 4 h in the presence of DTT, indicating that the enzyme was stable under the dialysis conditions used as long as DTT was present in the buffer. To determine whether the reducing agent was needed to prevent formation of disulfide bond(s) or to avoid oxidation of a critical residue, the disulfide bond-specific reductant TCEP (9) was added to protein that had been dialyzed in the absence of reducing agent. TCEP failed to restore any detectable activity to PrpB suggesting that an oxidation-sensitive residue may play a crucial role in catalysis.

Metal requirement. The PrpB protein from serovar Typhimurium required a divalent metal cation for maximal activity. Mg²⁺ ions (2.5 mM) supported the highest specific activity of the enzyme. The apparent K_m for Mg²⁺ under these assay conditions was 38 µM. Equimolar concentrations of Mn²⁺ ions supported activity, but only at 28% of the specific activity of PrpB with Mg²⁺. Ca²⁺ ions failed to support lyase activity and were in fact slightly inhibitory (data not shown).

Ionic strength. Increases in the ionic strength in the assay resulted in decreased specific activity of the PrpB enzyme. PrpB retained 81% of its specific activity at 50 mM NaCl, 63% at 100 mM NaCl, and only retained 41% of its activity at 250 mM NaCl. These data were consistent with reports of ICL inhibition by inorganic anions (43).

Substrate specificity. The PrpB enzyme of serovar Typhimurium appears to be specifically designed to cleave 2-MIC; PrpB did not cleave isocitrate at any detectable levels, even after incubation with isocitrate for 24 h.

Kinetic parameters. Based on four independent trials, the K_m of H₆PrpB for 2-MIC was 19 µM, with a k_cat of 105 s^-1 for the tetrameric enzyme. The K_m of the detagged PrpB protein for 2-MIC was 18 µM, with a k_cat of 74 s^-1 (Table 2). The observed reduction in k_cat of detagged PrpB enzyme could be due to inactivation of the enzyme during removal of the hexahistidine tag, which was performed in the absence of reductant.

View this table: [in this window] [in a new window]

TABLE 2. Kinetic parameters for PrpB and mutant PrpB proteinsa

Residues essential for 2-MIC cleavage. Previous studies on ICL enzymes and elucidation of the crystal structure of the enzymes with bound inhibitors (5, 6, 21, 26, 34), and similar studies of PEP mutase from Mytilus edulis (19, 20), identified residues that affect the catalytic activities of these enzymes. Mutations in equivalent residues in the prpB gene were constructed, including residues C123 (the proposed active site base of ICL), D58, H125, K121, and R122 (Fig. 2). Mutant PrpB proteins from plasmids pPRP82, pPRP84-86, and pPRP132 were overproduced and purified using nickel chelation chromatography. Immunoblot analysis showed that all mutant proteins were stable (data not shown) and showed only minor differences in the electrophoretic behavior relative to that of the wild-type protein in nondenaturing polyacrylamide gels; these differences were likely due to subtle changes in the isoelectric points of the proteins (Fig. 4). The electrophoretic behavior of all mutant PrpB proteins was consistent with the reported tetrameric quaternary state of PrpB from E. coli (7, 11) and serovar Typhimurium (H. Holden and I. Rayment, unpublished results).

View larger version (46K): [in this window] [in a new window]

FIG. 4. Electrophoretic behavior of wild-type and mutant PrpB proteins under nondenaturing conditions. Conditions for nondenaturing PAGE were as described above. The protein used is indicated above each lane. Numbers in parentheses indicate the change in isoelectric point in comparison to H6PrpB. Size markers used were bovine serum albumin (66 kDa) and ß-amylase (200 kDa) (Sigma).

2-MICL activity of mutant PrpB proteins. Table 2 shows the kinetic values obtained for wild-type and mutant PrpB proteins for the cleavage of 2-MIC. Proteins PrpB^R122K, PrpB^H125A, and PrpB^K121A retained measurable activity. The subtle R122K change resulted in a 50% decrease in k_cat, while the other mutations of the proposed active site loop region of PrpB (K¹²¹RCGH¹²⁵) resulted in more drastic decreases in activity of the enzyme. The C123A change (corresponding to a residue in the active site loop of ICLs) abolished all detectable activity, as did the D58A mutation. These results showed that both the C123 and D58 residues of PrpB were essential for catalysis. With the exception of protein PrpB^R122K, all mutant PrpB proteins were unable to compensate for the lack of PrpB in prpB mutants during growth on propionate. Even though the catalytic efficiency of the PrpB^R122K was only half of that of the wild-type enzyme, no measurable difference in the doubling time during growth on propionate was observed between strains carrying plasmid pPRP75 (encoding PrpB) or pPRP132 (encoding PrpB^R122K) (doubling time = 4.2 h each).

Can PrpB be converted into an ICL by mutation? Ways of distinguishing genes encoding ICLs from those encoding 2-MICLs have been suggested (28). Because all characterized ICLs contain a KKCGH motif while all known 2-MICLs contain a corresponding KRCGH motif, it has been proposed that 2-MICL enzymes might be recognized by a KRCGH motif while ICLs may be recognized by the KKCGH sequence (7). To determine whether residue R122 of PrpB was involved in substrate specificity, a R122K change was introduced by site-directed mutagenesis and the resulting protein was assayed for ICL and 2-MICL activities. The PrpB^R122K protein retained about 50% of the 2-MICL activity, and still failed to cleave isocitrate at any detectable level. These results indicate that a single change in the KKCGH motif does not change the specificity of the 2-MICL enzyme for its substrate. A likely explanation for having R122 in 2-MICLs is that an arginine residue is required in this position of the protein to facilitate closure of the active site loop over the substrate, similarly to that proposed for K189 of Mycobacterium tuberculosis ICL (34).

Identification of lesions in prpB generated by random chemical mutagenesis and stability of the resulting proteins. The prpB allele of previously isolated prpB mutant strains (JE3946 and JE3961) was sequenced to determine whether the mutations were in the active site of PrpB. Both strains carried only one amino acid change. In strain JE3946 prpB had a change at position E188 to a lysine (E188K), while strain JE3961 contained a G55K change. Mutant protein PrpB^G55K was stable as determined by immunoblot analysis. This mutation most likely caused a propionate phenotype due to a disruption in the positioning of the nearby crucial D58 residue. In contrast, protein PrpB^E188K was unstable (data not shown), suggesting that this amino acid change likely disrupted protein folding making the protein sensitive to degradation.

Top Abstract Introduction Materials and Methods Results Discussion References

 
This work was undertaken to gain insights into the reaction mechanism of the 2-MICL (PrpB) enzyme of serovar Typhimurium. The PrpB enzyme was purified and kinetically characterized, and the roles of conserved residues were investigated both in vitro and in vivo.

The wild-type PrpB enzyme of serovar Typhimurium. Kinetic parameters have been determined for the PrpB enzyme from E. coli. In the study by Brock et al. (7), PrpB from E. coli was determined to have a K_m of 19 µM for 2-MIC and a K_m of 35 µM for Mg²⁺. The close agreement of the kinetic parameters determined for the PrpB enzyme of serovar Typhimurium (K_m of 19 µM for 2-MIC and a K_m of 38 µM for Mg²⁺) to those reported for the E. coli PrpB protein was expected considering that the amino acid sequence of these two enzymes is 90% identical. Unlike the E. coli enzyme, however, the serovar Typhimurium enzyme was able to use Mn²⁺ instead of Mg²⁺ ions, albeit poorly. The activity of PrpB from serovar Typhimurium required a reducing agent for maximal activity, which has also been observed in ICL and in PrpB enzymes from E. coli and A. nidulans (7, 43). However, failure of the disulfide-specific reductant TCEP to reactivate oxidized, inactive PrpB enzyme, suggested the need to prevent a redox active residue (such as a cysteine) from oxidizing, rather than preventing a disulfide bond from forming.

Insights into the PrpB reaction mechanism. Hypotheses of the PrpB reaction mechanism were proposed based on mechanisms for ICL and PEP mutase proteins with which the PrpB protein shares homology (7, 20). On the basis of the work reported here, it is hypothesized that the mechanism of PrpB action is similar to that of ICL based on the similarities in structure of substrates, and in similarities between the active site loop region between ICL and 2-MICL, i.e., the K(R/K)CGH motif. Both ICL and E. coli PrpB can be inactivated by treatment with cysteine-modifying agents (7, 31). Our data indicate that residue C123 is critical to catalysis.

The three-dimensional crystal structure of serovar Typhimurium apo-PrpB has been solved to a 2.1-Å resolution (H. Holden and I. Rayment, unpublished results). The structure confirms the oligomeric state of PrpB to be a dimer of dimers; the structure of the monomer is an atypical /ß-barrel similar to the one of PEP mutase and ICL (5, 6, 19, 34). The region of the polypeptide spanning residue C123, however, is disordered, most likely due to the lack of substrate in the active site. Based on similarities of PrpB to ICL and data presented here, it is hypothesized that residue C123 serves as the active site base of PrpB and residue D58 is required for the binding of the Mg²⁺ ion. Elucidation of the structure of PrpB complexed with its substrate in the active site will provide further insights into the reaction mechanism of this enzyme.

During the review of this work, the three-dimensional crystal structure of E. coli PrpB protein was published (11). In this structure, the active-site loop was modeled in place based on the structure of the ligand-bound M. tuberculosis ICL. In this structure, residue D58 appears critical to the positioning of a Mg²⁺ ion in the active site. Our results would support the proposed role for residue D58. In the same structure, active-site residue R122 does not appear to play a role in substrate recognition because it points away from the active site in the modeled loop. The authors postulate that the reaction mechanism proceeds identically to the ICL mechanism based on similarities in structure.

 
This work was supported by grant NIH grants GM62203 (to J.C.E.-S) and GM58281 (to I. R.).

We thank W. W. Cleland (University of Wisconsin—Madison) for the kind gift of 2-MIC, and J. Beckwith (Harvard University) for plasmid pBAD30.

 
* Corresponding author. Mailing address: Department of Bacteriology, University of Wisconsin, 1710 University Ave., Madison, WI 53726-4087. Phone: (608) 262-7379. Fax: (608) 265-7909. E-mail: escalante{at}bact.wisc.edu.

Top Abstract Introduction Materials and Methods Results Discussion References

 

1
1. Altschul, S. F., W. Gish, W. Miller, and E. W. Myers. 1990. Basic local alignment search tool. J. Mol. Biol. 215:403-410.[CrossRef][Medline]
2
2. Altschul, S. F., T. L. Madden, A. A. Schaffer, J. Zhang, W. Miller, and D. J. Lipmann. 1997. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res. 25:3389-3402.[Abstract/Free Full Text]
3
3. Berkowitz, D., J. M. Hushon, H. J. Whitfield, J. Roth, and B. N. Ames. 1968. Procedure for identifying nonsense mutations. J. Bacteriol. 96:215-220.[Abstract/Free Full Text]
4
4. Bradford, M. M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248-255.[CrossRef][Medline]
5
5. Britton, K., S. Langridge, P. J. Baker, K. Weeradechapon, S. E. Sedelnikova, J. R. De Lucas, D. W. Rice, and G. Turner. 2000. The crystal structure and active site location of isocitrate lyase from the fungus Aspergillus nidulans. Struct. Fold Des. 8:349-362.[Medline]
6
6. Britton, K. L., I. S. Abeysinghe, P. J. Baker, V. Barynin, P. Diehl, S. J. Langridge, B. A. McFadden, S. E. Sedelnikova, T. J. Stillman, K. Weeradechapon, and D. W. Rice. 2001. The structure and domain organization of Escherichia coli isocitrate lyase. Acta Crystallogr. D Biol. Crystallogr. 57:1209-1218.[CrossRef][Medline]
7
7. Brock, M., D. Darley, S. Textor, and W. Buckel. 2001. 2-Methylisocitrate lyases from the bacterium Escherichia coli and the filamentous fungus Aspergillus nidulans characterization and comparison of both enzymes. Eur. J. Biochem. 268:3577-3586.[Medline]
8
8. Brock, M., C. Maerker, A. Schutz, U. Volker, and W. Buckel. 2002. Oxidation of propionate to pyruvate in Escherichia coli. Involvement of methylcitrate dehydratase and aconitase. Eur. J. Biochem. 269:6184-6194.[Medline]
9
9. Burns, J. A., J. C. Butler, J. Moran, and G. M. Whitesides. 1991. Selective reduction of disulfides by Tris(2-caboxyethyl)phosphine. J. Org. Chem. 56:2648-2650.[CrossRef]
10
10. Dawson, R. M. C., D. C. Elliott, W. H. Elliott, and K. M. Jones. 1986. Data for biochemical research, 3rd ed. Oxford University Press, Oxford, United Kingdom.
11
11. Grimm, C., A. Evers, M. Brock, C. Maerker, G. Klebe, W. Buckel, and K. Reuter. 2003. Crystal structure of 2-methylisocitrate lyase (PrpB) from Escherichia coli and modelling of its ligand bound active centre. J. Mol. Biol. 328:609-621.[CrossRef][Medline]
12
12. Guzman, L.-M., D. Belin, M. J. Carson, and J. Beckwith. 1995. Tight regulation, modulation, and high-level expression by vectors containing arabinose P_BAD promoter. J. Bacteriol. 177:4121-4130.[Abstract/Free Full Text]
13
13. Hidaka, T., S. Imai, O. Hara, H. Anzai, T. Murakami, K. Nagaoka, and H. Seto. 1990. Carboxyphosphoenolpyruvate phosphomutase, a novel enzyme catalyzing C-P bond formation. J. Bacteriol. 172:3066-3072.[Abstract/Free Full Text]
14
14. Horswill, A. R., and J. C. Escalante-Semerena. 2002. Characterization of the propionyl-CoA synthetase (PrpE) enzyme of Salmonella enterica: residue Lys592 is required for propionyl-AMP synthesis. Biochemistry 41:2379-2387.[CrossRef][Medline]
15
15. Horswill, A. R., and J. C. Escalante-Semerena. 2001. In vitro conversion of propionate to pyruvate by Salmonella enterica enzymes: 2-methylcitrate dehydratase (PrpD) and aconitase enzymes catalyze the conversion of 2-methylcitrate to 2-methylisocitrate. Biochemistry 40:4703-4713.[CrossRef][Medline]
16
16. Horswill, A. R., and J. C. Escalante-Semerena. 1997. Propionate catabolism in Salmonella typhimurium LT2: two divergently transcribed units comprise the prp locus at 8.5 centisomes, prpR encodes a member of the sigma-54 family of activators, and the prpBCDE genes constitute an operon. J. Bacteriol. 179:928-940.[Abstract/Free Full Text]
17
17. Horswill, A. R., and J. C. Escalante-Semerena. 1999. The prpE gene of Salmonella typhimurium LT2 encodes propionyl-CoA synthetase. Microbiology 145:1381-1388.[Abstract/Free Full Text]
18
18. Horswill, A. R., and J. C. Escalante-Semerena. 1999. Salmonella typhimurium LT2 catabolizes propionate via the 2-methylcitric acid cycle. J. Bacteriol. 181:5615-5623.[Abstract/Free Full Text]
19
19. Huang, K., Z. Li, Y. Jia, D. Dunaway-Mariano, and O. Herzberg. 1999. Helix swapping between two alpha/beta barrels: crystal structure of phosphoenolpyruvate mutase with bound Mg²⁺-oxalate. Struct. Fold Des. 7:539-548.[Medline]
20
20. Jia, Y., Z. Lu, K. Huang, O. Herzberg, and D. Dunaway-Mariano. 1999. Insight into the mechanism of phosphoenolpyruvate mutase catalysis derived from site-directed mutagenesis studies of active site residues. Biochemistry 38:14165-14173.[CrossRef][Medline]
21
21. Ko, Y. H., and B. A. McFadden. 1990. Alkylation of isocitrate lyase from Escherichia coli by 3-bromopyruvate. Arch. Biochem. Biophys. 278:373-380.[CrossRef][Medline]
22
22. Laemmli, U. K. 1970. Cleavage and structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685.[CrossRef][Medline]
23
23. Liu, S., Z. Lu, Y. Jia, D. Dunaway-Mariano, and O. Herzberg. 2002. Dissociative phosphoryl transfer in PEP mutase catalysis: structure of the enzyme/sulfopyruvate complex and kinetic properties of mutants. Biochemistry 41:10270-10276.[CrossRef][Medline]
24
24. Luttik, M. A., P. Kotter, F. A. Salomons, I. J. van Der Klei, J. P. van Dijken, and J. T. Pronk. 2000. The Saccharomyces cerevisiae ICL2 gene encodes a mitochondrial 2-methylisocitrate lyase involved in propionyl-coenzyme A metabolism. J. Bacteriol. 182:7007-7113.[Abstract/Free Full Text]
25
25. Michael, S. F. 1994. Mutagenesis by incorporation of a phosphorylated oligo during PCR amplification. BioTechniques 16:410-414.[Medline]
26
26. Nimmo, H. G., F. Douglas, C. Kleanthous, D. G. Campbell, and C. Mackintosh. 1989. Identification of a cysteine residue at the active site of Escherichia coli isocitrate lyase. Biochem. J. 261:431-435.[Medline]
27
27. Ogawa, Y., T. Tsuruoka, S. Inoue, and T. Niida. 1973. Studies on a new antibiotic SF-1293. II. Chemical structure of antibiotic SF-1293. Sci. Rep. Meijii Kaisha 13:42-48.
28
28. Rehman, A., and B. A. McFadden. 1997. Cysteine 195 has a critical functional role in catalysis by isocitrate lyase from Escherichia coli. Curr Microbiol. 35:267-269.[CrossRef][Medline]
29
29. Ryu, J.-I., and R. J. Hartin. 1990. Quick transformation of Salmonella typhimurium LT2. BioTechniques 8:43-45.
30
30. Sasse, J. 1991. Detection of proteins, p. 10.6.1-10.6.8. In F. A. Ausubel, R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Struhl (ed.), Current protocols in molecular biology, vol. 1. Wiley Interscience, New York, N.Y.
31
31. Schloss, J. V., and W. W. Cleland. 1982. Inhibition of isocitrate lyase by 3-nitropropionate, a reaction intermediate analogue. Biochemistry 21:4420-4427.[CrossRef][Medline]
32
32. Seidel, H. M., and J. R. Knowles. 1994. Interaction of inhibitors with phosphoenolpyruvate mutase: implications for the reaction mechanism and the nature of the active site. Biochemistry 33:5641-5646.[CrossRef][Medline]
33
33. Seidman, C. G., K. Struhl, J. Sheen, and T. Jessen. 1997. Introduction of plasmid DNA into cells, p. 1.8.-1.8.10. In F. M. Ausubel, R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Struhl (ed.), Current protocols in molecular biology, vol. 1. Wiley Interscience, New York, N.Y.
34
34. Sharma, V., S. Sharma, K. Hoener zu Bentrup, J. D. McKinney, D. G. Russell, W. R. Jacobs, Jr., and J. C. Sacchettini. 2000. Structure of isocitrate lyase, a persistence factor of Mycobacterium tuberculosis. Nat. Struct. Biol. 7:663-668.[CrossRef][Medline]
35
35. Tabor, S. 1990. Expression using the T7 RNA polymerase/promoter system., p. 16.2.1.-16.2.11. In F. M. Ausubel, R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Struhl (ed.), Current protocols in molecular biology, vol. 2. Wiley Interscience, New York, N.Y.
36
36. Tabuchi, T., and S. Hara. 1974. Production of 2-methylcitric acid from n-paraffins by mutants of Candida lipolytica. Agric. Biol. Chem. 38:1105-1106.
37
37. Tabuchi, T., and N. Serizawa. 1975. The production of 2-methylisocitric acid from odd-carbon n-alkanes by a mutant of Candida lipolytica. Agric. Biol. Chem. 39:1049-1054.
38
38. Tabuchi, T., H. Umetsu, H. Aoki, and H. Uchiyama. 1995. Characteristics of 2-methylisocitrate dehydratase, isolated from Yarrowia lipolytica, in comparison with aconitase. Biosci. Biotechnol. Biochem. 59:2013-2017.
39
39. Textor, S., V. F. Wendisch, A. A. De Graaf, U. Müller, M. I. Linder, D. Linder, and W. Buckel. 1997. Propionate oxidation in Escherichia coli: evidence for operation of a methylcitrate cycle in bacteria. Arch. Microbiol. 168:428-436.[CrossRef][Medline]
40
40. Thompson, J. D., D. G. Higgins, and T. J. Gibson. 1994. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acid Res. 22:4673-4680.[Abstract/Free Full Text]
41
41. Tsai, S. P., R. J. Hartin, and J. Ryu. 1989. Transformation in restriction-deficient Salmonella typhimurium LT2. J. Gen. Microbiol. 135:2561-2567.[Medline]
42
42. Tsang, A. W., A. R. Horswill, and J. C. Escalante-Semerena. 1998. Studies of regulation of expression of the propionate (prpBCDE) operon provide insights into how Salmonella typhimurium LT2 integrates its 1,2-propanediol and propionate catabolic pathways. J. Bacteriol. 180:6511-6518.[Abstract/Free Full Text]
43
43. Vanni, P., E. Giachetti, G. Pinzauti, and B. A. McFadden. 1990. Comparative structure, function and regulation of isocitrate lyase, an important assimilatory enzyme. Comp. Biochem. Physiol. 95:431-458.
44
44. Way, J. C., M. A. Davis, D. Morisato, D. E. Roberts, and N. Kleckner. 1984. New Tn10 derivatives for transposon mutagenesis and for construction of lacZ operon fusions by transposition. Gene 32:369-379.[CrossRef][Medline]
45
45. Winston, S. E., S. A. Fuller, and J. G. R. Hurrell. 1990. Western blotting, p. 10.8.1-10.8.6. In F. A. Ausubel, R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Struhl (ed.), Current protocols in molecular biology, vol. 1. Wiley Interscience, New York, N.Y.

---

Journal of Bacteriology, August 2003, p. 4837-4843, Vol. 185, No. 16
0021-9193/03/$08.00+0     DOI: 10.1128/JB.185.16.4837-4843.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.

This article has been cited by other articles:

• Upton, A. M., McKinney, J. D. (2007). Role of the methylcitrate cycle in propionate metabolism and detoxification in Mycobacterium smegmatis. Microbiology 153: 3973-3982 [Abstract] [Full Text]  
• Kim, Y. R., Brinsmade, S. R., Yang, Z., Escalante-Semerena, J., Fierer, J. (2006). Mutation of Phosphotransacetylase but Not Isocitrate Lyase Reduces the Virulence of Salmonella enterica Serovar Typhimurium in Mice. Infect. Immun. 74: 2498-2502 [Abstract] [Full Text]  
• Brock, M. (2005). Generation and Phenotypic Characterization of Aspergillus nidulans Methylisocitrate Lyase Deletion Mutants: Methylisocitrate Inhibits Growth and Conidiation. Appl. Environ. Microbiol. 71: 5465-5475 [Abstract] [Full Text]  
• Grimek, T. L., Escalante-Semerena, J. C. (2004). The acnD Genes of Shewenella oneidensis and Vibrio cholerae Encode a New Fe/S-Dependent 2-Methylcitrate Dehydratase Enzyme That Requires prpF Function In Vivo. J. Bacteriol. 186: 454-462 [Abstract] [Full Text]  

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Grimek, T. L. Articles by Escalante-Semerena, J. C. Search for Related Content PubMed PubMed Citation Articles by Grimek, T. L. Articles by Escalante-Semerena, J. C.